Aim: Transcatheter closure of an ostium secundum atrial septal defect (ASD) is now considered the standard care for most of children with the appropriate anatomy, and is a relatively well-tolerated procedure to reduce the clinical sequelae of ASD, with a low complication rate.
Methods: The present case reports describe our clinical experience of the percutaneous closure of a secundum ASD in 10 children between December 2011 and November 2012, by means of a new generation of device, the GORE Septal Occluder device.
Results: The implantation was successful in all except two cases, the device being properly placed and deployed without malposition or embolization in the catheterization laboratory. No complications were related to the procedure. The successful implant was confirmed and no major adverse events were documented in the following 3-12 months.
Conclusion: The new GORE Septal Occluder device appears to be a feasible, well-tolerated and successful tool for the closure of an ASD of 15 mm or less in childhood.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2459/JCM.0000000000000036 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Temporary microaxial transvalvular left ventricular assist device for post-myocardial infarction ventricular septal rupture: Bridging a paradigm shift.
JTCVS Tech
December 2024
Department of Thoracic and Cardiovascular Surgery, Kaufman Center for Heart Failure Treatment and Recovery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
Objective: To characterize the clinical courses and outcomes of patients presenting with post-myocardial infarction (MI) ventricular septal rupture (VSR) receiving temporary microaxial transvalvular left ventricular assist device (tVAD) support.
Methods: Between December 2019 and July 2023, 10 consecutive patients presented with a post-MI VSR. All 10 patients received a tVAD.
Rescue Transcatheter Native Aortic Valve Closure to Treat Severe Aortic Regurgitation in a Patient With Single Ventricular Physiology and Decompensated Heart Failure.
Catheter Cardiovasc Interv
January 2025
Department of Paediatric Cardiology, Leeds Teaching Hospitals Trust, Leeds, UK.
Semilunar valve regurgitation in single ventricular physiology is rare but portends a poor prognosis. Medical therapy is often ineffective particularly in the context of structural valve abnormality, and surgical valve repair or replacement can be associated with poor outcomes. We report an innovative use of a highly occlusive and conformable Gore Septal Occluder for transcatheter treatment of severe native aortic regurgitation in a symptomatic patient with hypoplastic left heart syndrome and severe systemic right ventricular dysfunction, resulting in safe and complete occlusion of the aortic regurgitant orifice and clinical benefit.
View Article and Find Full Text PDFInfected right ventricular outflow tract pseudoaneurysm in an infant with tetralogy of Fallot: Successful palliation using a Gore VBX covered stent.
Ann Pediatr Cardiol
October 2024
Department of Pediatrics, Division of Pediatric Cardiology, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.
Article Synopsis
- - The text discusses a rare complication called pseudoaneurysm that can occur in the right ventricular outflow tract (RVOT) after cardiac surgeries, particularly in a 3-month-old infant with tetralogy of Fallot and pulmonary atresia.
- - The patient was critically ill with septic shock and very high pressure in the right ventricle, requiring urgent treatment to avoid high-risk surgery.
- - The successful management involved using a Gore VBX balloon expandable covered stent to exclude the pseudoaneurysm and stenting the pulmonary arteries to relieve pressure, highlighting the importance of recognizing this condition and available treatment options.
Practice variation using the hybrid stage I procedure in congenital heart disease: Results from a national survey.
JTCVS Open
October 2024
Division of Pediatric Cardiology, Department of Pediatrics, University of Michigan, Ann Arbor, Mich.
Article Synopsis
- Hybrid stage I palliation is a procedure used mainly for high-risk patients with single ventricle heart disease, serving various roles such as a starter treatment or a bridge to more complex surgeries or transplants.
- A survey sent to congenital heart centers in the U.S. and Canada revealed that about 45 out of 106 centers perform this type of palliation, with a majority using pulmonary artery bands and ductal stents for management.
- There is significant variation in the practices and indications for hybrid stage I palliation among centers, highlighting the need for multicenter studies to establish standardized protocols and improve patient outcomes.
Comparative Effectiveness of Devices for Interventional Patent Foramen Ovale Closure: Insights from a 23-Year Monocentric Analysis.
J Clin Med
October 2024
Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany.
Patent foramen ovale (PFO) is a congenital heart defect affecting up to 25% of the population, associated with an increased risk of cryptogenic stroke. Percutaneous PFO closure is a minimally invasive procedure aimed at reducing stroke risk by eliminating the right-to-left shunt. This monocentric, retrospective study analyzed 716 patients who underwent PFO closure between January 2000 and February 2023.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!